Literature DB >> 19918

Ocular encephalitozoonosis (nosematosis) in blue foxes. Polyarteritis nodosa and cataract.

K Arnesen, K Nordstoga.   

Abstract

In young blue foxes an association has previously been established between the protozoon Encephalitozoon (Nosema) cuniculi and generalized arterial lesions of the polyarteritis nodosa type. The same vascular changes are found in the posterior ciliary arteries and their intraocular branches of these foxes. Most of the eyes which are thus affected, have a severe cataract. The parasite can easily be demonstrated both in the arteries and the lenses. It is thought that the Encephalitozoon is the cause of the vascular lesions and the cataract, and that possibly an autoimmune reaction is involved.

Entities:  

Mesh:

Year:  1977        PMID: 19918     DOI: 10.1111/j.1755-3768.1977.tb05662.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

1.  Brain and spinal cord lesions in encephalitozoonosis in mink.

Authors:  I Bjerkås
Journal:  Acta Vet Scand       Date:  1990       Impact factor: 1.695

2.  Experimental encephalitozoonosis in the blue fox. Clinical and serological examinations of affected pups.

Authors:  S F Mohn
Journal:  Acta Vet Scand       Date:  1982       Impact factor: 1.695

3.  Gastrointestinal parasites of arctic foxes (Vulpes lagopus) and sibling voles (Microtus levis) in Spitsbergen, Svalbard.

Authors:  Eva Myšková; Marek Brož; Eva Fuglei; Jana Kvičerová; Anna Mácová; Bohumil Sak; Martin Kváč; Oleg Ditrich
Journal:  Parasitol Res       Date:  2019-11-15       Impact factor: 2.289

4.  Feline intralenticular Encephalitozoon cuniculi: three cases from California.

Authors:  Joie Lin; Barbara Nell; Taemi Horikawa; Mitzi Zarfoss
Journal:  JFMS Open Rep       Date:  2022-08-02

Review 5.  More than a rabbit's tale - Encephalitozoon spp. in wild mammals and birds.

Authors:  Barbara Hinney; Bohumil Sak; Anja Joachim; Martin Kváč
Journal:  Int J Parasitol Parasites Wildl       Date:  2016-01-08       Impact factor: 2.674

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.